Curious about Trustmark (TRMK) Q2 Performance? Explore Wall Street Estimates for Key Metrics

21.07.25 15:15 Uhr

Werte in diesem Artikel
Aktien

76,00 EUR -0,50 EUR -0,65%

32,40 EUR -0,40 EUR -1,22%

Indizes

21.058,0 PKT 37,9 PKT 0,18%

Wall Street analysts expect Trustmark (TRMK) to post quarterly earnings of $0.86 per share in its upcoming report, which indicates a year-over-year increase of 30.3%. Revenues are expected to be $201.33 million, up 8.3% from the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.Given this perspective, it's time to examine the average forecasts of specific Trustmark metrics that are routinely monitored and predicted by Wall Street analysts.Analysts' assessment points toward 'Efficiency Ratio' reaching 62.7%. Compared to the current estimate, the company reported 63.8% in the same quarter of the previous year.The collective assessment of analysts points to an estimated 'Total nonaccrual LHFI' of $87.77 million. Compared to the current estimate, the company reported $44.29 million in the same quarter of the previous year.Analysts predict that the 'Total nonperforming assets' will reach $98.06 million. The estimate is in contrast to the year-ago figure of $50.88 million.The combined assessment of analysts suggests that 'Average Balances - Total earning assets' will likely reach $16.88 billion. The estimate is in contrast to the year-ago figure of $17.19 billion.Analysts forecast 'Net Interest Income' to reach $156.91 million. Compared to the current estimate, the company reported $141.03 million in the same quarter of the previous year.It is projected by analysts that the 'Net Interest Income (FTE)' will reach $159.15 million. The estimate is in contrast to the year-ago figure of $144.33 million. View all Key Company Metrics for Trustmark here>>> Shares of Trustmark have demonstrated returns of +13.1% over the past month compared to the Zacks S&P 500 composite's +5.4% change. With a Zacks Rank #2 (Buy), TRMK is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .One Big Gain, Every Trading DayTo help you take full advantage of this market, you’re invited to access every stock recommendation in all our private portfolios - for just $1.Zacks private portfolio services that closed 256 double and triple-digit winners in 2024 alone. That’s about one big gain every day the market was open. Of course, not all our picks are winners, but members have seen recent gains as high as +627% +1,340%, and +1,708%.Imagine how much you could profit with a steady stream of real-time picks from all our services that cover a number of strategies to suit a variety of investing and trading styles.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Trustmark Corporation (TRMK): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Q2

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Q2 Holdings Inc

Wer­bung

Analysen zu Q2 Holdings Inc

DatumRatingAnalyst
13.08.2019Q2 BuyCompass Point
01.03.2019Q2 BuyNeedham & Company, LLC
19.12.2018Q2 BuyBTIG Research
09.08.2018Q2 BuyNeedham & Company, LLC
11.05.2018Q2 NeutralBTIG Research
DatumRatingAnalyst
13.08.2019Q2 BuyCompass Point
01.03.2019Q2 BuyNeedham & Company, LLC
19.12.2018Q2 BuyBTIG Research
09.08.2018Q2 BuyNeedham & Company, LLC
16.02.2018Q2 BuyNeedham & Company, LLC
DatumRatingAnalyst
11.05.2018Q2 NeutralBTIG Research
18.11.2016Q2 Sector WeightPacific Crest Securities Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen